Assignee
TARGEGEN INC
US·8 granted patents·11 pending applications·377 citations·filing 2003–2012
Top patents by PatentIndex Score
19 records- 0197US7528143B2Bi-aryl meta-pyrimidine inhibitors of kinasesTARGEGEN INC·Filed 2006·Granted May 5, 2009·220 cites·44 claims
- 0295US7825246B2Bi-aryl meta-pyrimidine inhibitors of kinasesTARGEGEN INC·Filed 2007·Granted Nov 2, 2010·40 cites·9 claims
- 0391US7652051B2Heterocyclic compounds and methods of useTARGEGEN INC·Filed 2005·Granted Jan 26, 2010·16 cites·15 claims
- 0491US7208493B2Vasculostatic agents and methods of use thereofTARGEGEN INC·Filed 2003·Granted Apr 24, 2007·68 cites·9 claims
- 0586US7691858B2Kinase inhibitors and methods of use thereofTARGEGEN INC·Filed 2007·Granted Apr 6, 2010·11 cites·7 claims
- 0685US8030487B22-amino—5-substituted pyrimidine inhibitorsTARGEGEN INC·Filed 2007·Granted Oct 4, 2011·10 cites·34 claims
- 0785US7456176B2Benzotriazine inhibitors of kinasesTARGEGEN INC·Filed 2005·Granted Nov 25, 2008·11 cites·34 claims
- 0872US8372971B2Heterocyclic compounds and methods of useTARGEGEN INC·Filed 2011·Granted Feb 12, 2013·1 cites·22 claims
- 0961US2010278811A1Vasculostatic agents and methods of use thereofTARGEGEN INC·Filed 2009·Application pending·0 cites
- 1058US2013243754A1Heterocyclic compounds and methods of useTARGEGEN INC·Filed 2012·Application pending·0 cites
- 1156US2007161645A1Thiazole inhibitors targeting resistant kinase mutationsTARGEGEN INC·Filed 2006·Application pending·0 cites
- 1255US2005282814A1Vasculostatic agents and methods of use thereofTARGEGEN INC·Filed 2005·Application pending·0 cites
- 1354US2007208019A1Vasculostatic agents and methods of use thereofTARGEGEN INC·Filed 2007·Application pending·0 cites
- 1453US2006292203A1Methods and compositions for the treatment of ocular disordersTARGEGEN INC·Filed 2006·Application pending·0 cites
- 1551US2011269721A1Methods of treating thalassemiaTARGEGEN INC·Filed 2009·Application pending·0 cites
- 1651US2011166149A1Pteridine derivatives for treating respiratory diseaseTARGEGEN INC·Filed 2009·Application pending·0 cites
- 1751US2007149508A1Six membered heteroaromatic inhibitors targeting resistant kinase mutationsTARGEGEN INC·Filed 2006·Application pending·0 cites
- 1846US2010330030A1Vasculostatic Agents and Methods of Use ThereofTARGEGEN INC·Filed 2010·Application pending·0 cites
- 1941US2006247250A1Pyrimidine inhibitors of kinasesTARGEGEN INC·Filed 2006·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →